Gennaro Marco Falco

11PUBLICATIONS
48CO-AUTHORS
AutoimmunityPharmaceutical delivery technologiesImmunology not elsewhere classifiedGene and molecular therapyPsychiatry (incl. psychotherapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 22, 2026
The Psoriasis-Eczema Interface: Clinical Classification and Therapeutic Implications From a Bicentric Experience.

|Mar 30, 2026
Superior Clinical and Economic Value of IL-23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis.

Gennaro Marco Falco, Elena Ippoliti, Niccolò Gori

|Sep 01, 2025
No Increased Risk of Thromboembolic Events During 6-Month Treatment With Baricitinib in Patients With Alopecia Areata.

Giacomo Caldarola, Antonietta Ferretti, Lorenzo Maria Pinto

|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.

Riccardo Balestri, Giulia Odorici, Michela Magnano

|Oct 07, 2024
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies.

Giacomo Caldarola, Eleonora De Luca, Gennaro Marco Falco

|Oct 02, 2024
Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab.

Gennaro Marco Falco, Giacomo Caldarola, Alessandra D'Amore

Pageof 2

Frequent Collaborators

10 joint publications

Giacomo Caldarola

5 joint publications

Ketty Peris

2 joint publications

Andrea Chiricozzi

2 joint publications

Clara De Simone